These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 769266)
21. The University of California at Los Angeles heart transplantation experience. Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A Clin Transpl; 2005; ():173-85. PubMed ID: 17424734 [TBL] [Abstract][Full Text] [Related]
22. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450 [TBL] [Abstract][Full Text] [Related]
23. Pediatric heart transplantation at Stanford: results of a 15-year experience. Baum D; Bernstein D; Starnes VA; Oyer P; Pitlick P; Stinson E; Shumway N Pediatrics; 1991 Aug; 88(2):203-14. PubMed ID: 1861916 [TBL] [Abstract][Full Text] [Related]
24. Triple-drug immunosuppression for heart transplantation in infants and children. Brown JW; Turrentine MW; Kesler KA; Mahomed Y; Darragh R; Evans K; Thompson L; Caldwell R J Heart Lung Transplant; 1993; 12(6 Pt 2):S265-74. PubMed ID: 8312346 [TBL] [Abstract][Full Text] [Related]
27. Heart transplantation in Finland 1985-1995. Mattila S; Heikkilä L; Sipponen J; Verkkala K; Kyösola K; Mattila T; Järvinen A; Luosto R; Heikkinen L; Ketonen P; Salo J; Nemlander A; Mattila I; Nieminen MS Ann Chir Gynaecol; 1997; 86(2):113-20. PubMed ID: 9366983 [TBL] [Abstract][Full Text] [Related]
28. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths]. Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868 [TBL] [Abstract][Full Text] [Related]
29. Acute rejection and coronary artery disease in long-term survivors of heart transplantation. Narrod J; Kormos R; Armitage J; Hardesty R; Ladowski J; Griffith B J Heart Transplant; 1989; 8(5):418-20; discussion 420-1. PubMed ID: 2795285 [TBL] [Abstract][Full Text] [Related]
30. Stanford cardiac transplantation. A review. Dong E; Shumway NE Isr J Med Sci; 1975; 11(2-3):264-7. PubMed ID: 1089617 [TBL] [Abstract][Full Text] [Related]
31. Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. Pennock JL; Oyer PE; Reitz BA; Jamieson SW; Bieber CP; Wallwork J; Stinson EB; Shumway NE J Thorac Cardiovasc Surg; 1982 Feb; 83(2):168-77. PubMed ID: 7035753 [TBL] [Abstract][Full Text] [Related]
32. Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team. Chan GL; Weinstein SS; Vijayanagar RR Clin Transplant; 1995 Apr; 9(2):106-14. PubMed ID: 7599398 [TBL] [Abstract][Full Text] [Related]
33. Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft. Milano A; Caforio AL; Livi U; Bauce B; Angelini A; Casarotto D; Thiene G J Heart Lung Transplant; 1996 May; 15(5):456-60. PubMed ID: 8771500 [TBL] [Abstract][Full Text] [Related]
35. Effect of early cyclosporine levels on kidney allograft rejection. Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683 [TBL] [Abstract][Full Text] [Related]
36. Late complications in pediatric cardiac transplant recipients. Addonizio LJ; Hsu DT; Smith CR; Gersony WM; Rose EA Circulation; 1990 Nov; 82(5 Suppl):IV295-301. PubMed ID: 2225419 [TBL] [Abstract][Full Text] [Related]
37. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
38. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506 [TBL] [Abstract][Full Text] [Related]
39. The status of cardiac transplantation, 1975. Rider AK; Copeland JG; Hunt SA; Mason J; Specter MJ; Winkle RA; Bieber CP; Billingham ME; Dong E; Griepp RB; Schroeder JS; Stinson EB; Harrison DC; Shumway NE Circulation; 1975 Oct; 52(4):531-9. PubMed ID: 1098809 [TBL] [Abstract][Full Text] [Related]
40. The present status of heterotopic cardiac transplantation. Barnard CN; Barnard MS; Cooper DK; Curchio CA; Hassoulas J; Novitsky D; Wolpowitz A J Thorac Cardiovasc Surg; 1981 Mar; 81(3):433-9. PubMed ID: 7007744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]